{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:13:37Z","timestamp":1778091217897,"version":"3.51.4"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["WI1-179875"],"award-info":[{"award-number":["WI1-179875"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic disrupted healthcare utilization and access for many, with persons living with pre-existing pulmonary conditions like cystic fibrosis (pwCF) having been the most impacted. PwCF appeared to have improvements in lung function and reduction in pulmonary exacerbations during the pandemic. However, it is not clear if general healthcare utilization beyond CF centers were also reduced and whether there existed any sex-based differences in health outcomes during the pandemic. Our objective was to use population-level administrative data to gain a comprehensive understanding of healthcare utilization and outcomes for pwCF pre- compared to post-COVID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective provincial-level analysis was conducted using linked administrative datasets from a single-payer health jurisdiction in Alberta, Canada. We measured hospitalization, emergency department and outpatient visits in pwCF 18 months before and after March 12, 2020. Subgroup analysis was undertaken to differences between sexes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Acute care encounters (including general emergency department [ED] visits and hospitalizations) for pwCF declined during the pandemic. There was a trend towards an increase in outpatient primary care and specialist clinics (both virtual and in-person) in the post-COVID period. Mortality rate was largely unchanged during the pandemic. CF females and males experienced the same relative change in healthcare utilization during the pandemic with a greater reduction in ED visits by CF females.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PwCF accessed acute care resources less but females experienced a greater drop in ED visits despite similar hospitalization rates as males, raising the possibility that females with CF experienced a disproportionate barrier to accessing acute care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0345009","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:33:48Z","timestamp":1778088828000},"page":"e0345009","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of the COVID-19 pandemic on sex-related disparities in cystic fibrosis healthcare utilization and outcomes: A population study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-4575","authenticated-orcid":true,"given":"Jason","family":"Weatherald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winnie M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E.","family":"Ronksley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-2554","authenticated-orcid":true,"given":"Jeffrey A.","family":"Bakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8234-4760","authenticated-orcid":true,"given":"Michael K.","family":"Stickland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas P.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-193X","authenticated-orcid":true,"given":"Grace Y.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"6","key":"pone.0345009.ref001","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.arbres.2021.12.003","article-title":"The impact of COVID-19 in Cystic Fibrosis","volume":"58","author":"PA Flume","year":"2022","journal-title":"Archivos de Bronconeumolog\u00eda"},{"issue":"10","key":"pone.0345009.ref002","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1513\/AnnalsATS.202105-532OC","article-title":"Changes in care during the COVID-19 pandemic for people with cystic fibrosis","volume":"19","author":"DB Sanders","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"pone.0345009.ref003","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12931-023-02593-1","article-title":"The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review","volume":"24","author":"A Vitiello","year":"2023","journal-title":"Respir Res"},{"issue":"1","key":"pone.0345009.ref004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12890-021-01528-0","article-title":"Systematic review: cystic fibrosis in the SARS-CoV-2\/COVID-19 pandemic","volume":"21","author":"HR Mathew","year":"2021","journal-title":"BMC Pulm Med"},{"key":"pone.0345009.ref005","doi-asserted-by":"crossref","first-page":"958658","DOI":"10.3389\/fped.2022.958658","article-title":"Risk factors for severe COVID-19 in people with cystic fibrosis: a systematic review","volume":"10","author":"V Terlizzi","year":"2022","journal-title":"Front Pediatr"},{"issue":"2","key":"pone.0345009.ref006","article-title":"Impact of telehealth during the COVID-19 pandemic on clinical and nutritional conditions of adolescents with cystic fibrosis","volume":"50","author":"LM da S Reis","year":"2024","journal-title":"J Bras Pneumol"},{"issue":"3","key":"pone.0345009.ref007","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcf.2022.09.006","article-title":"Clinical outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic","volume":"22","author":"M Doumit","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"5","key":"pone.0345009.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30177-6","article-title":"Impact of COVID-19 on people with cystic fibrosis","volume":"8","author":"C Colombo","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"3","key":"pone.0345009.ref009","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11302-021-09771-0","article-title":"Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2","volume":"17","author":"EH Abraham","year":"2021","journal-title":"Purinergic Signalling"},{"issue":"12","key":"pone.0345009.ref010","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1089\/jwh.2014.4985","article-title":"Gender differences in outcomes of patients with cystic fibrosis","volume":"23","author":"CL Harness-Brumley","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"issue":"12","key":"pone.0345009.ref011","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1089\/jwh.2022.0128","article-title":"Impact of the COVID-19 pandemic on women\u2019s health care access: a cross-sectional study","volume":"31","author":"K Turner","year":"2022","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"pone.0345009.ref012","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/03007995.2016.1277196","article-title":"Frequency and costs of pulmonary exacerbations in patients with cystic fibrosis in the United States","volume":"33","author":"JL Rubin","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"pone.0345009.ref013","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/CEOR.S162021","article-title":"The burden of cystic fibrosis in the Medicaid population","volume":"10","author":"M Hassan","year":"2018","journal-title":"Clinicoecon Outcomes Res"},{"issue":"10","key":"pone.0345009.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"EI Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"11","key":"pone.0345009.ref015","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"H Quan","year":"2005","journal-title":"Med Care"},{"issue":"9","key":"pone.0345009.ref016","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1513\/AnnalsATS.202312-1078OC","article-title":"Impact of COVID-19 pandemic on chronic obstructive pulmonary disease healthcare use, exacerbations, and mortality: a population study","volume":"21","author":"GY Lam","year":"2024","journal-title":"Annal Am Thoracic Soc"},{"issue":"3","key":"pone.0345009.ref017","first-page":"00454","article-title":"Impact of COVID-19 pandemic on sex disparities in asthma healthcare utilisation and outcomes: a population study","volume":"11","author":"GY Lam","year":"2025","journal-title":"ERJ Open Res"},{"issue":"44","key":"pone.0345009.ref018","doi-asserted-by":"crossref","first-page":"27285","DOI":"10.1073\/pnas.2012520117","article-title":"Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries","volume":"117","author":"V Galasso","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pone.0345009.ref019","doi-asserted-by":"crossref","DOI":"10.1111\/hsc.13546","article-title":"The experience of delayed health care access during the COVID 19 pandemic in Australian women: a mixed methods exploration","volume":"30","author":"J White","year":"2022","journal-title":"Health Soc Care Community"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:33:52Z","timestamp":1778088832000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345009"}},"subtitle":[],"editor":[{"given":"Vipula Rasanga","family":"Bataduwaarachchi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345009","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]}}}